Advertisement
Novara — A Smarter Way to Access Global Markets
LIVE DESK·Global markets desk

Markets

Bitcoin treasury turns profitable as BTC tops $77,000
CryptoArticle

Bitcoin treasury turns profitable as BTC tops $77,000

Strategy’s corporate Bitcoin holdings break even after BTC surges past $75,385 cost basis. Analysts cite $68,000 as a critical support level amid renewed buying interest.

22 Aug 2026
NIBE Industrier shares rise on strong Q2 earnings, heat pump demand
EquitiesArticle

NIBE Industrier shares rise on strong Q2 earnings, heat pump demand

Swedish heat pump maker NIBE Industrier advanced after reporting a 9% operating margin in Q1 2026 and citing a 49% surge in German heat pump subsidy applications.

U.S. jobless claims drop to 206,000, beating forecasts
ForexArticle

U.S. jobless claims drop to 206,000, beating forecasts

Initial unemployment filings fell below expectations for a second straight week, signaling steady labor market conditions despite recent volatility.

NextTrip debuts B2B travel platform for advisors with zero subscription fee
ForexArticle

NextTrip debuts B2B travel platform for advisors with zero subscription fee

The NASDAQ-listed travel tech firm launches NextTrip Pro, a commission-based platform offering booking tools and group travel management at no cost to qualified travel professionals.

Argentina trade surplus widens to $2.12 bln in July
ForexArticle

Argentina trade surplus widens to $2.12 bln in July

Exports rose to $8.85 billion while imports climbed to $6.74 billion, exceeding analyst forecasts of $1.85 billion.

European metals stocks poised for gains if U.S.-Canada tariffs halve
EquitiesArticle

European metals stocks poised for gains if U.S.-Canada tariffs halve

Morgan Stanley analysis projects ArcelorMittal as the top beneficiary, with potential annualized pre-tax relief of $300-$350 million. Rio Tinto, SSAB and Norsk Hydro face mixed impacts.

Data centres seen consuming silver at scale of major miner’s output
CommoditiesArticle

Data centres seen consuming silver at scale of major miner’s output

World Silver Survey 2026 projects data centre demand to exceed 42 million ounces annually by 2027, reshaping industrial consumption patterns. Silver price near eight-week high as yields ease.

Swiss gasoline prices rise above 2 francs per liter for first time since 2022
CommoditiesArticle

Swiss gasoline prices rise above 2 francs per liter for first time since 2022

Average price for 95-octane gasoline reaches 2.02 francs per liter, driven by Middle East tensions, reduced refinery capacity and Rhine transport disruptions. Diesel climbs to 2.27 francs.

Harrow’s eye anesthesia gel shows 58% less discomfort in study
EquitiesArticle

Harrow’s eye anesthesia gel shows 58% less discomfort in study

IHEEZO gel outperformed proparacaine in a 50-patient trial, with statistically significant reductions in pain across all post-injection time points.

IntraGel raises $7M from UroGen for head and neck cancer therapy
EquitiesArticle

IntraGel raises $7M from UroGen for head and neck cancer therapy

Funds will advance TumoCure through Phase 2 trials after Phase 1b data showed safety and early efficacy. UroGen gains exclusive global rights option under the deal.

Aryzta shares drop 6% after UBS downgrades to sell on margin concerns
EquitiesArticle

Aryzta shares drop 6% after UBS downgrades to sell on margin concerns

Swiss bakery group’s stock falls as UBS cuts price target to CHF40 and slashes earnings forecasts, citing weaker growth and margin pressures in Germany and GLP-1 diet trends.

Moderna, Merck mRNA cancer vaccine hits milestone in melanoma trial
ForexArticle

Moderna, Merck mRNA cancer vaccine hits milestone in melanoma trial

Combined therapy shows first late-stage success for personalized mRNA cancer vaccine, driving Moderna shares up 150%. Keytruda patent cliff looms as rivals race to replicate results.

US equities mixed; SMI edges lower as oil hits four-week high
EquitiesArticle

US equities mixed; SMI edges lower as oil hits four-week high

Futures on the Dow slipped 0.13% while Nasdaq futures rose 0.1% ahead of U.S. open. Brent crude surged 2.6% to $94.04/bbl, nearing $100/bbl. Swiss Re and Logitech led SMI laggards.

LSI Industries CFO to retire in August 2027 after decade-long tenure
EquitiesArticle

LSI Industries CFO to retire in August 2027 after decade-long tenure

James E. Galeese, CFO since 2017, will step down after over 10 years with the Cincinnati-based lighting and display manufacturer. The company plans to name a successor by mid-2027.

D.E. Shaw discloses $1B+ stake in Sysco amid AI push
EquitiesArticle

D.E. Shaw discloses $1B+ stake in Sysco amid AI push

Hedge fund D.E. Shaw reveals a more than $1 billion stake in Sysco, as the food distributor accelerates AI-driven efficiency gains and eyes a major acquisition. Sysco’s stock has underperformed over the past year.

Michelin shares rise 1.7% after JPMorgan upgrade to Overweight
EquitiesArticle

Michelin shares rise 1.7% after JPMorgan upgrade to Overweight

Stock climbs to €34.68 as JPMorgan lifts price target to €42, citing accelerating truck tire demand and durable growth in high-tech composites.

Euronext wheat hits four-week high as Black Sea disruptions curb exports
CommoditiesArticle

Euronext wheat hits four-week high as Black Sea disruptions curb exports

Benchmark wheat prices surged 1.8% to €241 per metric ton on Euronext amid escalating war-related shipping disruptions in the Black Sea, redirecting demand to Western Europe.

Gold rises as Trump escalates economic pressure on Iran
CommoditiesArticle

Gold rises as Trump escalates economic pressure on Iran

U.S. sanctions threat against Iran lifts gold, oil prices; Fed rate-hike odds remain low ahead of Jackson Hole. Analysis flags technical resistance and profit-taking risks.

Ultragenyx surges 11% after FDA approval of gene therapy for rare disease
EquitiesArticle

Ultragenyx surges 11% after FDA approval of gene therapy for rare disease

Ultragenyx shares jumped 11.1% in pre-market trading after the FDA granted accelerated approval for GENGLYCOS, the company's first gene therapy. Analysts raised price targets to as high as $58.